Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

G-Plans vs Levers Health

G-Plans
Graded #463

Higher grade

vs+0.5
Levers Health
Graded #469

Lower grade

The verdict

G-Plans takes it — 53.8/100 to 53.3/100, but only just.

G-Plans grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Personalized nutrition and weight loss program with optional GLP-1 medication add-on. Levers Health is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueG-Plans +11
45
34
Dose & formulationLevers Health +14
40
54
Clinical oversightG-Plans +1
72
71
Labs & monitoringEven
53
53
FulfillmentG-Plans +3
65
62
Contract termsEven
55
55
G-Plans · left barLevers Health · right bar

The numbers

MetricG-PlansLevers Health
WeighScore53.8/10053.3/100
GradeCC
Scorecard rank#463#469
SemaglutideNot disclosed$247/mo (1.25 mg dose, compounded)
TirzepatideNot disclosed$296/mo (5 mg dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
G-Plans

Graded #463 · C

Strengths

  • Both semaglutide and tirzepatide available

Where it loses points

  • Pricing not publicly disclosed
Levers Health

Graded #469 · C

Strengths

  • Named LLC entity
  • Microdose GLP-1 option marketed for longevity
  • Both semaglutide and tirzepatide available

Where it loses points

  • No LegitScript or PCAB accreditation
  • No physical address disclosed
  • State availability not disclosed
  • FAQ and terms pages return 404
  • Above-average pricing ($247-$396/mo); tirzepatide any-dose plan is $396/mo (only the up-to-5mg low-dose plan is $296)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard